Literature DB >> 21546076

Dengue vector control strategies in an urban setting: an economic modelling assessment.

Paula Mendes Luz1, Tazio Vanni, Jan Medlock, A David Paltiel, Alison P Galvani.   

Abstract

BACKGROUND: An estimated 2·5 billion people are at risk of dengue. Incidence of dengue is especially high in resource-constrained countries, where control relies mainly on insecticides targeted at larval or adult mosquitoes. We did epidemiological and economic assessments of different vector control strategies.
METHODS: We developed a dynamic model of dengue transmission that assesses the evolution of insecticide resistance and immunity in the human population, thus allowing for long-term evolutionary and immunological effects of decreased dengue transmission. We measured the dengue health burden in terms of disability-adjusted life-years (DALYs) lost. We did a cost-effectiveness analysis of 43 insecticide-based vector control strategies, including strategies targeted at adult and larval stages, at varying efficacies (high-efficacy [90% mortality], medium-efficacy [60% mortality], and low-efficacy [30% mortality]) and yearly application frequencies (one to six applications). To assess the effect of parameter uncertainty on the results, we did a probabilistic sensitivity analysis and a threshold analysis.
FINDINGS: All interventions caused the emergence of insecticide resistance, which, with the loss of herd immunity, will increase the magnitude of future dengue epidemics. In our model, one or more applications of high-efficacy larval control reduced dengue burden for up to 2 years, whereas three or more applications of adult vector control reduced dengue burden for up to 4 years. The incremental cost-effectiveness ratios of the strategies for two high-efficacy adult vector control applications per year was US$615 per DALY saved and for six high-efficacy adult vector control applications per year was $1267 per DALY saved. Sensitivity analysis showed that if the cost of adult control was more than 8·2 times the cost of larval control then all strategies based on adult control became dominated.
INTERPRETATION: Six high-efficacy adult vector control applications per year has a cost-effectiveness ratio that will probably meet WHO's standard for a cost-effective or very cost-effective intervention. Year-round larval control can be counterproductive, exacerbating epidemics in later years because of evolution of insecticide resistance and loss of herd immunity. We suggest the reassessment of vector control policies that are based on larval control only. FUNDING: The Fulbright Programme, CAPES (Brazilian federal agency for post-graduate education), the Miriam Burnett trust, and the Notsew Orm Sands Foundation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21546076      PMCID: PMC3409589          DOI: 10.1016/S0140-6736(11)60246-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Climatic factors associated with epidemic dengue in Palembang, Indonesia: implications of short-term meteorological events on virus transmission.

Authors:  Michael J Bangs; Ria P Larasati; Andrew L Corwin; Suharyono Wuryadi
Journal:  Southeast Asian J Trop Med Public Health       Date:  2006-11       Impact factor: 0.267

2.  Modelling the control strategies against dengue in Singapore.

Authors:  M N Burattini; M Chen; A Chow; F A B Coutinho; K T Goh; L F Lopez; S Ma; E Massad
Journal:  Epidemiol Infect       Date:  2007-05-31       Impact factor: 2.451

3.  Insecticide resistance mechanisms of Brazilian Aedes aegypti populations from 2001 to 2004.

Authors:  Isabela Reis Montella; Ademir Jesus Martins; Priscila Fernandes Viana-Medeiros; José Bento Pereira Lima; Ima Aparecida Braga; Denise Valle
Journal:  Am J Trop Med Hyg       Date:  2007-09       Impact factor: 2.345

4.  Impact of insecticide interventions on the abundance and resistance profile of Aedes aegypti.

Authors:  P M Luz; C T Codeço; J Medlock; C J Struchiner; D Valle; A P Galvani
Journal:  Epidemiol Infect       Date:  2009-01-12       Impact factor: 2.451

5.  Disability adjusted life years lost to dengue in Brazil.

Authors:  P M Luz; B Grinsztejn; A P Galvani
Journal:  Trop Med Int Health       Date:  2009-01-20       Impact factor: 2.622

6.  Spatial and temporal patterns in the recovery of Aedes aegypti (Diptera: Culicidae) populations after insecticide treatment.

Authors:  C J M Koenraadt; J Aldstadt; U Kijchalao; A Kengluecha; J W Jones; T W Scott
Journal:  J Med Entomol       Date:  2007-01       Impact factor: 2.278

7.  Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti.

Authors:  Jose A Suaya; Donald S Shepard; Moh-Seng Chang; Mariana Caram; Stefan Hoyer; Duong Socheat; Ngan Chantha; Michael B Nathan
Journal:  Trop Med Int Health       Date:  2007-09       Impact factor: 2.622

8.  Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama.

Authors:  Blas Armien; Jose A Suaya; Evelia Quiroz; Binod K Sah; Vicente Bayard; Loyd Marchena; Cornelio Campos; Donald S Shepard
Journal:  Am J Trop Med Hyg       Date:  2008-09       Impact factor: 2.345

9.  Characterization of a dengue patient cohort in Recife, Brazil.

Authors:  Marli Tenório Cordeiro; Ana Maria Silva; Carlos A A Brito; Eduardo J M Nascimento; Maria Cecilia F Magalhães; Georgia F Guimarães; Norma Lucena-Silva; Eduardo M Freese de Carvalho; Ernesto T A Marques
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

Review 10.  Economic burden of dengue infections in India.

Authors:  Pankaj Garg; Jitender Nagpal; Prakash Khairnar; Suranjith L Seneviratne
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-04-09       Impact factor: 2.184

View more
  52 in total

1.  Emerging infections of the central nervous system.

Authors:  Jennifer Lyons; Justin McArthur
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

2.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 3.  Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.

Authors:  Dagna Constenla; Cristina Garcia; Noah Lefcourt
Journal:  Pharmacoeconomics       Date:  2015-11       Impact factor: 4.981

4.  Knowledge, Attitudes, and Preventive Practices Regarding Dengue in Maracay, Venezuela.

Authors:  Jelte Elsinga; Masja Schmidt; Erley F Lizarazo; Maria F Vincenti-Gonzalez; Zoraida I Velasco-Salas; Luzlexis Arias; Johannes G M Burgerhof; Adriana Tami
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

5.  Dengue Incidence and Sociodemographic Conditions in Pucallpa, Peruvian Amazon: What Role for Modification of the Dengue-Temperature Relationship?

Authors:  Margot Charette; Lea Berrang-Ford; Oliver Coomes; Elmer Alejandro Llanos-Cuentas; César Cárcamo; Manisha Kulkarni; Sherilee L Harper
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

6.  Coverage-dependent effect of insecticide-treated curtains for dengue control in Thailand.

Authors:  Veerle Vanlerberghe; Yuwadee Trongtokit; Somchai Jirarojwatana; Ravisara Jirarojwatana; Audrey Lenhart; Chamnarn Apiwathnasorn; Philip J McCall; Patrick Van der Stuyft
Journal:  Am J Trop Med Hyg       Date:  2013-05-13       Impact factor: 2.345

7.  Dengue seroprevalence and risk factors for past and recent viral transmission in Venezuela: a comprehensive community-based study.

Authors:  Zoraida I Velasco-Salas; Gloria M Sierra; Diamelis M Guzmán; Julio Zambrano; Daniel Vivas; Guillermo Comach; Jan C Wilschut; Adriana Tami
Journal:  Am J Trop Med Hyg       Date:  2014-09-15       Impact factor: 2.345

8.  Managing patients with dengue fever during an epidemic: the importance of a hydration tent and of a multidisciplinary approach.

Authors:  Alexandre R Marra; Gustavo Faissol Janot de Matos; Renata Donato Janeri; Patricia Sousa Machado; Claudio Schvartsman; Oscar Fernando Pavão Dos Santos
Journal:  BMC Res Notes       Date:  2011-09-08

9.  Novel dengue virus NS2B/NS3 protease inhibitors.

Authors:  Hongmei Wu; Stefanie Bock; Mariya Snitko; Thilo Berger; Thomas Weidner; Steven Holloway; Manuel Kanitz; Wibke E Diederich; Holger Steuber; Christof Walter; Daniela Hofmann; Benedikt Weißbrich; Ralf Spannaus; Eliana G Acosta; Ralf Bartenschlager; Bernd Engels; Tanja Schirmeister; Jochen Bodem
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

Review 10.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.